
Federal Circuit Reverses Injunction That Barred Clinical Trials in Jazz v. Avadel
The Federal Circuit recently considered the scope of a permanent injunction that prohibited a drug manufacturer from conducting certain clinical and regulatory activities in Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals LLC, No. 24-2274 (Fed. …